← All companies ← MCY Manual MDB → ← LFST Health Care Providers & Services NHC →

MD, Pediatrix Medical Group Inc.

Health Care Providers & Services diversified CyclicalSerial acquirer

Pediatrix is a leading provider of physician services including newborn, maternal-fetal, and other pediatric subspecialty care.

Our neonatal physicians interact with colleagues across the country through an internal communications system to draw upon their collective expertise in managing challenging patient-care issues.

Latest annual: FY2025 10-K

MD · Pediatrix Medical Group Inc.

The business

What it sells, where the money comes from, the kind of company it is.

Revenue · FY2025

$1.9B

−4.9% YoY · 2% 5-yr CAGR

Vital signs · TTM, with 5-yr average

Revenue $1.9B 5-yr avg $2.0B

Operating margin 11.3% 5-yr avg 5.4%

ROIC 13% 5-yr avg 7%

Owner-earnings margin 12% 5-yr avg 7%

Free cash flow margin 12% 5-yr avg 7%

The business in brief

read the 10-K →

What this business is and what moves its needle, from its own SEC filings.

Situation: Cyclical. Margins collapse and recover repeatedly across the record; a single year, good or bad, misstates the through-cycle earning power. Serial acquirer. Goodwill and acquired intangibles are 57% of assets, with meaningful acquisition spending in 4 of the record's 10 years; much of what this business is was bought, at prices the record carries.
What moves the needle: Operating margin has run about 10% through the cycle, a thin margin, where volume, cost discipline and the price it gets all bear on the result. The operating margin has swung widely — from −3.4% to 18% over the years — so the through-cycle figure carries more than any single year, and the worst year more than the best. Read this kind of business on volume, payer mix and reimbursement. On its own account, the filing leans hardest on pricing power & competition, set against the numbers in what the filing emphasizes, below.
Is it a good business?: Return on capital has sat near the cost of capital (median 8%). By owner earnings: roughly 11% of revenue reaches owners as cash, consistently. The cycle and the balance sheet decide this one; the worst year tells more than the median, and the rest is in the 10-K.

Every line is arithmetic on the company's filings, shown in full in the sections below.

The record

Ten years of arithmetic, read across the cycle.

The record, 2016–2025

realized figures from each filing · older years to the left

2016’16	2017’17	2018’18	2019’19	2020’20	2021’21	2022’22	2023’23	2024’24	2025’25	TTMTTMMar 2026
											Income statement
$3.2B	$3.3B	$1.7B	$1.8B	$1.7B	$1.9B	$2.0B	$2.0B	$2.0B	$1.9B	$1.9B	RevenueRevenue
12%	12%	13%	14%	14%	14%	12%	11%	12%	13%	13%	SG&A / revenueSG&A/rev
$572M	$455M	$248M	$172M	$98M	$203M	$173M	$7M	($69M)	$209M	$218M	Operating incomeOp. inc.
18.0%	14.0%	14.4%	9.7%	5.7%	10.6%	8.8%	0.4%	−3.4%	10.9%	11.3%	Operating marginOp. mgn
$325M	$320M	$269M	($1.5B)	($796M)	$131M	$66M	($60M)	($99M)	$165M	$174M	Net incomeNet inc.
37%	20%	14%	—	—	17%	22%	—	—	24%	23%	Effective tax rateTax rate
											Cash flow & returns
$444M	$511M	$314M	$358M	$205M	$77M	$167M	$137M	$207M	$271M	$259M	Operating cash flowOp. cash
$89M	$79M	$24M	$26M	$28M	$32M	$36M	$36M	$32M	$22M	$23M	DepreciationDeprec.
($4M)	$83M	($16M)	$1.8B	$934M	($105M)	$49M	$149M	$262M	$66M	$43M	Working capital & otherWC & other
$39M	$26M	$17M	$19M	$29M	$32M	$30M	$33M	$22M	$18M	$21M	CapexCapex
1.2%	0.8%	1.0%	1.1%	1.7%	1.7%	1.5%	1.7%	1.1%	1.0%	1.1%	Capex / revenueCapex/rev
$405M	$485M	$297M	$338M	$176M	$44M	$137M	$104M	$185M	$253M	$237M	Owner earningsOwner earn.
12.7%	14.9%	17.2%	19.0%	10.1%	2.3%	7.0%	5.2%	9.2%	13.2%	12.3%	Owner earnings marginOE mgn
$405M	$485M	$297M	$338M	$176M	$44M	$137M	$104M	$185M	$253M	$237M	Free cash flowFCF
12.7%	14.9%	17.2%	19.0%	10.1%	2.3%	7.0%	5.2%	9.2%	13.2%	12.3%	Free cash flow marginFCF mgn
$762M	$531M	$65M	$0	$2M	$30M	$28M	$7M	$8M	$23M	$30M	AcquisitionsAcquis.
$62M	$70M	$302M	$145M	$8M	$5M	$89M	$919K	$2M	$87M	—	BuybacksBuybacks
8%	7%	4%	—	—	11%	—	—	-5%	15%	13%	ROICROIC
12%	10%	9%	-100%	-107%	15%	7%	-7%	-13%	19%	20%	Return on equityROE
12%	10%	9%	−100%	−107%	15%	7%	−7%	−13%	19%	20%	Retained to equityRetained/eq
											Balance sheet
$56M	$40M	$132M	$108M	$1.1B	$387M	$10M	$73M	$230M	$375M	$206M	Cash & investmentsCash+inv
$495M	$504M	$507M	$434M	$242M	$302M	$297M	$272M	$260M	$230M	$225M	ReceivablesReceiv.
$28M	$35M	$31M	$35M	$60M	$37M	$32M	$35M	$46M	$37M	$32M	Accounts payablePayables
$467M	$469M	$476M	$399M	$182M	$265M	$265M	$238M	$214M	$192M	$193M	Operating working capitalOper. WC
$587M	$627M	$660M	$732M	$1.5B	$841M	$428M	$483M	$640M	$764M	$587M	Current assetsCur. assets
$449M	$531M	$503M	$542M	$444M	$427M	$427M	$389M	$434M	$459M	$443M	Current liabilitiesCur. liab.
1.3×	1.2×	1.3×	1.4×	3.5×	2.0×	1.0×	1.2×	1.5×	1.7×	1.3×	Current ratioCurr. ratio
$3.8B	$4.3B	$4.1B	$1.5B	$1.5B	$1.5B	$1.5B	$1.4B	$1.2B	$1.3B	$1.3B	GoodwillGoodwill
$5.3B	$5.9B	$5.9B	$4.1B	$3.3B	$2.7B	$2.3B	$2.2B	$2.2B	$2.2B	$2.1B	Total assetsAssets
$1.7B	$1.8B	$2.0B	$1.7B	$1.7B	$990M	$637M	$622M	$611M	$600M	$631M	Total debtDebt
$1.6B	$1.8B	$1.8B	$1.6B	$576M	$602M	$627M	$549M	$381M	$225M	$425M	Net debt / (cash)Net debt
9.1×	6.1×	2.7×	1.4×	0.9×	3.0×	4.4×	0.2×	-1.7×	5.8×	6.2×	Interest coverageInt. cov.
$2.8B	$3.1B	$3.1B	$1.5B	$747M	$896M	$892M	$849M	$765M	$866M	$879M	Shareholders’ equityEquity
1.1%	0.9%	2.1%	1.9%	2.3%	1.0%	0.8%	0.6%	0.6%	0.9%	1.0%	Stock comp / revenueSBC/rev
—	—	—	$1.4B	—	—	—	$148M	$151M	—	—	Goodwill written downGW imp.
											Per share
93.1M	93.0M	91.6M	84.0M	83.4M	85.8M	84.1M	82.2M	83.3M	85.3M	83.1M	Shares out (diluted)Shares
$34.19	$35.00	$18.81	$21.18	$20.79	$22.27	$23.44	$24.27	$24.16	$22.45	$23.25	Revenue / shareRev/sh
$3.49	$3.45	$2.93	$-17.83	$-9.55	$1.53	$0.79	$-0.73	$-1.19	$1.94	$2.10	EPS (diluted)EPS
$4.34	$5.22	$3.24	$4.03	$2.11	$0.52	$1.63	$1.27	$2.21	$2.96	$2.86	Owner earnings / shareOE/sh
$4.34	$5.22	$3.24	$4.03	$2.11	$0.52	$1.63	$1.27	$2.21	$2.96	$2.86	Free cash flow / shareFCF/sh
$0.42	$0.28	$0.19	$0.23	$0.35	$0.38	$0.35	$0.41	$0.26	$0.22	$0.26	Cap. spending / shareCapex/sh
$29.65	$32.99	$33.71	$17.84	$8.96	$10.45	$10.60	$10.33	$9.18	$10.15	$10.58	Book value / shareBVPS

Per-share growththe realized rate an owner's share compounded

	9-yr	5-yr
Revenue / share	−4.6%/yr	+1.5%/yr
Owner earnings / share	−4.2%/yr	+7.0%/yr
EPS	−6.3%/yr	—
Capital spending / share	−7.1%/yr	−8.9%/yr
Book value / share	−11.2%/yr	+2.5%/yr

The record, charted

FY2016–2025

Each measure over its full record; the current point and the worst year marked.

Share count

85Mpeak FY2016

ROIC

15%low FY2024

Net debt ÷ owner earnings

0.9×peak FY2021

Owner earnings vs. net income

Owner earningsNet income

The accountant's number, and the cash an owner can take; the gap is the tell.

$253Mowner earningsvs.$165Mnet incomelow FY2021

Where the cash went

ReinvestBuybacksDividendsAcquisitionsRetainedBeyond op. cash

Each year's outlays against its operating cash: the mix, and how it drifts. The hatched cap is spending beyond that year's operating cash — financed from the balance sheet or borrowing, not operations.

FY2016FY2025

Owner-earnings bridge

FY2021–FY2025cash-flow statement, SEC EDGAR →

Net income is the accountant's number; owner earnings is the cash an owner could take out. The walk between them, off the cash-flow statement, and whether the gap is widening or holding.

In fiscal 2025 the business turned $165M of profit into $253M of owner earnings: more cash than the profit line showed, after the non-cash charges and the capital it put back in.

Reported net income$165M

Owner earnings$253M · 13% of revenue

	FY2025	FY2024	FY2023	FY2022	FY2021
Reported net income	$165M	($99M)	($60M)	$66M	$131M
Depreciation & amortizationnon-cash charge added back	+$22M	+$32M	+$36M	+$36M	+$32M
Stock-based compensationreal costnon-cash, but a real cost	+$18M	+$12M	+$12M	+$16M	+$19M
Working capital & othertiming of cash in and out, other non-cash items	+$66M	+$262M	+$149M	+$49M	−$105M
Cash from operations	$271M	$207M	$137M	$167M	$77M
Capital expenditurecash put back in to keep running and to grow	−$18M	−$22M	−$33M	−$30M	−$32M
Owner earnings	$253M	$185M	$104M	$137M	$44M
Owner-earnings marginowner earnings ÷ revenue	13%	9%	5%	7%	2%

Owner earnings is the cash an owner could pull out without starving the business: operating cash less the capital it must spend to hold its position . The cash-flow statement also adds stock comp back as non-cash, but it is a real cost paid in shares; counted as the expense it is (less $18M), owner earnings is nearer $235M.

Maintenance capex is estimated as depreciation where a growing business invests above it; free cash flow is the figure the scorecard's free-cash margin reads.

III

Quality & stewardship

Returns, the balance sheet, capital allocation, and pay.

Owner’s Scorecard

FY2025 10-K · source on SEC EDGAR →

Will it survive?

Can it pay its interest? 5.8×

Comfortable

Operating income $209M ÷ interest expense $36M

What this means
Operating profit covers interest with the kind of margin Graham wanted for a defensive holding. Necessary, not sufficient, it says solvent, not cheap.
How heavy is the debt, net of cash? $256M · 1.2× operating profit

Modest net debt

Cash $375M − debt $631M

What this means
Netting $375M of cash and short-term investments against $631M of debt leaves $256M owed, about 1.2× a year's operating profit (3.0× on the gross debt, before the cash). Net debt is the leverage figure that matters: the cash is already set against the debt. Strategic or illiquid investments aren't counted here.
How long is cash tied up? —

Not enough data

What this means
The filing data didn't include the inputs for this check.

Is it a good business?

Return on invested capital 7%

Below average through the cycle

6-yr median, range -5%–15%; 14% latest = NOPAT $160M ÷ invested capital $1.1B

Industry peers: median 8%

What this means
The rate the business earns on the money tied up in it, Buffett's north star, because over time a stock tracks the ROIC beneath it. Above ~15% sustained hints at a moat; a return below the cost of capital (~8%) erodes value as a business grows rather than building it — the test Buffett weighs most. The headline is the median of the last 6 years (it ran 14% most recently), so one peak or trough year doesn't set the verdict. Asset-light businesses (R&D expensed, little capital) read artificially high, pair this with Owner Earnings.
Owner-earnings margin 10%

Solid through the cycle

10-yr median margin, range 2%–19%; latest $253M = operating cash $271M − maintenance capex $18M

Industry peers: median 5%

What this means
What an owner could take out without starving the business: operating cash less the maintenance capital it must spend to hold its position — Buffett's owner earnings. That's 13% of revenue this year, a 10% median across 10 years. Treating stock comp as the real expense it is (less $18M of SBC) leaves $235M.
Are earnings backed by cash? 1.64×

Cash-backed

Cash from ops $271M ÷ net income $165M

What this means
How much of reported profit showed up as operating cash. Above 1× is reassuring; well below suggests earnings lean on accruals. One year is noisy, growth and working-capital swings distort it, and this is operating cash, not free cash. Watch the multi-year trend.

How is the cash used?

Where do the earnings go? 34%

Reinvests most of it

Dividends + buybacks $87M ÷ Owner Earnings $253M

What this means
Of $253M Owner Earnings, $87M (34%) went back to shareholders, $0 dividends, $87M buybacks. Net of $18M stock comp, the real buyback was about $69M. Returning most of it is the mark of a mature business with little left to reinvest at a high return; reinvesting most could mean a long runway, or empire-building. The split doesn't say which; the return earned on it (see ROIC) does.
Investing or harvesting? 0.85×

Maintaining

Capex $18M ÷ depreciation $22M

What this means
Descriptive, not a grade. Above ~1× means investing faster than assets wear out (growth, or, sustained for years, today's earnings carrying less depreciation than tomorrow's will). Below means spending less than it's wearing out (efficiency, or a melting asset base). The ratio won't tell you which; the filings will.

Graham’s defensive tests · 0 of 6 met

Graham’s numerical criteria for the defensive investor (The Intelligent Investor, ch. 14), run on the filings. A floor of safety, not a buy signal; many fine modern businesses fail his strictest liquidity rules by design.

Adequate size Near

Revenue ≥ $2B · $1.9B

What this means
Big enough to weather a storm. Graham's 1972 floor was ~$100M of sales (≈ $700M today); we use a $2B revenue line as a conservative modern stand-in.
Strong liquidity Near

Current ratio ≥ 2× · 1.66×

What this means
Current assets at least twice current liabilities, near-term bills covered without touching the business. Strict by design: many cash-rich modern firms run leaner and miss it, holding their cushion in longer-dated securities.
Conservative debt Miss

Debt ≤ working capital · $631M vs $305M WC

What this means
Graham's rule that borrowings not exceed net current assets. Capital-heavy and buyback-heavy firms routinely fail it, read it next to interest coverage, not alone.
Earnings stability Miss

A profit every year (10-yr record) · 4 loss years

What this means
Graham wanted earnings in each of the past ten years, the stability a defensive owner leans on.
Dividend record Miss

Uninterrupted dividends · none paid

What this means
An unbroken dividend was Graham's mark of durability. He wanted twenty years; the filings show about ten, and a single suspension breaks the streak. Non-payers, many fine modern compounders, fall outside his defensive net by design.
Earnings growth Miss

Earnings +33% over the record · −99%

What this means
At least a third more earnings than a decade ago, averaging three years at each end. Net income (not per-share), so stock splits don't distort it, buybacks and dilution show up in the share-count line instead.
Moderate price —

P/E ≤ 15 and P/E × P/B ≤ 22.5 · decided by the price

What this means
Graham's valuation gate, the wall he kept between a sound business and a sound investment. Three-year average earnings are $0.02/share (latest year $2.01), the averaged base the calculator's gate runs on, and book value is $10.54/share. Enter a price in “What the price implies” just below for the P/E, P/B, and whether it clears. But this is the rule Buffett outgrew: there's no hard P/E law, and a wonderful business can deserve a far richer multiple if the thesis holds, treat it as the bargain-hunter's floor, not a verdict on the price.

Durability & moat, 2016–2025

Whether the record’s returns held, and what the capital reinvested earned.

Profitable years 6 of 10

What this means
Lost money in 4 year(s), look at what happened there before trusting the average.
Return on capital ≥ 15% 0 of 10 yrs

What this means
A moat shows up as a high return on invested capital that holds year after year, not one good vintage.
Operating margin 15% → 3% (3-yr avg ends)

What this means
Through the cycle the operating margin slipped — about 15% early to 3% lately, median 10% — competition or costs are biting in.
Reinvestment, incremental ROIC returns capital

What this means
The capital base barely grew: this business returns cash through dividends and buybacks rather than reinvesting. Judge it on the cash returned, not on compounding.
Owner earnings growth −8%/yr

What this means
Owner earnings shrank about 8% a year over the record.
Worst year 2024 · −3.4% op. margin

What this means
Operations went underwater in 2024, understand why before trusting the good years.
Share count −1.0%/yr

What this means
The share count is shrinking, buybacks are quietly growing your slice of the business.
How management talks about it Promotional

What this means
The returns have faded, yet the filing reaches for a promoter’s vocabulary — world-class, best-in-class, disruptive — more than an owner’s. When the words sell harder than the results deliver, the gap is the thing to weigh.

Does AI threaten the moat?

Moderate contestability

AI is likely to reshape costs and some products here without clearly contesting or sparing the core moat; how the company itself frames it is the tell.

The question is whether a moat the record shows as durable outlasts a technology that lowers the cost of part of what the firm sells. The durability is read in the record above, the filing's own framing of AI beside it; the industry label decides nothing on its own.

Read from the filing's own risk factors, paired with the industry's structure under its SIC code; the durability is read above, the price below.

All figures as filed; the source filing is linked above.

Current Position

as of the latest quarter, Mar 31, 2026

Can the business pay what it owes this year, off the freshest balance sheet: the quality of the assets, the debt actually coming due, and what a low ratio means here.

Current assets$587M

Cash & short-term investments$206M
Receivables$225M
Other current assets$156M

Current liabilities$443M

Debt due within a year$20M
Accounts payable$32M
Other current liabilities$391M

Current ratio1.33×all current assets ÷ what's due · Graham looked for 2×

Quick ratio1.33×stricter: inventory excluded

Cash ratio0.46×strictest: cash alone against what's due

Working capital$144Mthe cushion left after near-term bills

Debt due this year vs. cash$20M due · $206M cash covered by cash on hand, no refinancing forced · both figures from the Mar 31, 2026 balance sheet

Revenue, latest quarter vs. a year ago+3.9%the freshest read on whether the business is still growing

Current ratio, recent quarters1.4× → 1.3×

Deeper floors

Tangible book value($406M)equity stripped of goodwill & intangibles

Net current asset value($605M)Graham's net-net: current assets less all liabilities

Debt incl. operating leases$670M$39M of it operating leases

From the company's latest filing.

How the cash was used, 2016–2025

Over the record, the business generated $2.7B of operating cash; how management split it reads as a deleverager, a meaningful share of cash went to paying down debt.

Reinvested$266M · 10%
Buybacks$770M · 29%
Retained (debt / cash)$1.7B · 61%

Returned to owners$770M
32% of the owner earnings the business produced over the span, $0 as dividends and $770M as buybacks.
Source of fundingOperating cash
Operating cash covered reinvestment and returns; over the span debt fell $1.1B and cash and short-term investments rose $150M.
Average price paid for buybacks—
Buybacks ran $770M over the span, but a stock split in the window left the reported buyback-share counts on a basis the diluted-share count doesn't match, so a comparable average price can't be drawn.
Net change in share count−10.8%
The diluted count fell from 93M to 83M, so the buybacks outran the stock issued to staff.
Dividend record—
No dividend line was reported in the filing data over the span; the record here neither confirms nor rules out a payout.

Buybacks are gross of stock issued to staff; the share-count line above is the net of that, the figure that decides whether owners gained. The average price paid blends a year of purchases (and any accelerated repurchase), so it is close, not exact. The record of where the cash went and on what terms.

Acquisitions & goodwill

from the balance sheet & the 10-year cash-flow record

Goodwill grows only when a company acquires and falls only when it concedes it overpaid. The size of that bet, the cash put into buying rather than building, and how much has already been written off.

Goodwill & intangibles$1.3B57% of all assets; the premium carried on the balance sheet for businesses acquired

Against book equityexceeds itgoodwill alone is larger than the company’s entire book equity; stripped of the acquisition premium, there is no net book worth

Cash spent acquiring$1.5Bover 10 years buying other businesses, against $266M of capital spent building

$1.7B written down across 3 years (2019, 2023, 2024): goodwill the company has already conceded it overpaid for, charged against earnings. A write-down costs no cash (the cash went out when the deal was signed), but it is management marking its own past judgment to market.

Goodwill, acquired intangibles and equity from the latest balance sheet; acquisition spend and write-downs summed across the 10-year record, from the company's own filings.

Management, ownership & pay

read the proxy →

From the proxy: how much of the business the people running it own, and how they are paid, beside what the business earned for its owners in the same years.

Fiscal year	Pay, as filed	“Actually paid”	Owner earnings
2021	$6.8M	$9.0M	$44M
2022	$4.7M	$541k	$137M
2023	$2.2M	$1.6M	$104M
2024	$3.3M	$4.4M	$185M
2025	$2.8M	$3.0M	$253M
2025	$14.1M	$24.9M	$253M

Both pay figures are the company’s own, from the pay-versus-performance table its proxy statement files. “As filed” is the Summary Compensation Table total: salary, bonus, and equity awards at their value on the day of grant. “Actually paid” is the SEC’s prescribed recalculation, which re-marks those equity awards to what they became as they vested; it can swing far above or below the filed figure in either direction, and negative years occur. Owner earnings are the whole business's, from the record above, for the same fiscal years.

Insider ownership1.8%
The stake all directors and executive officers hold together, per the 2026 proxy: skin in the game, the first thing Munger reads.
CEO pay ratio91:1
What the chief earns for every dollar the median employee makes, per the 2026 proxy. A high ratio alone settles nothing; some businesses are genuinely top-heavy in scarce skill. A runaway figure is where Buffett starts asking whether the board is doing its job.
Stock-based compensation$18M
The slice of the business handed to employees in shares this year, 1% of revenue, equal to 9% of operating profit. Buffett's oldest accounting fight: this is compensation, compensation is an expense, real whether or not the headline earnings admit it. One trap: the cash-flow statement adds SBC back, so the operating cash, and the owner earnings drawn from it, are flattered by exactly this amount; counted as the cost it is, what an owner keeps is lower.

Inverting the record

Invert: instead of why Pediatrix Medical Group Inc. is a good business, the question is what would make owning it a mistake, and whether those marks are in the record. Disconfirming tests across 2016–2025.

1 of the 5 tests turned up something to look into; the other 4 came back clean.

Look hereIs it less profitable than it was?9.2% vs 14.9%
The owner-earnings margin averaged 14.9% early in the record and 9.2% across the last three years, and the latest year has not recovered. Ask the filing whether that is a structural drift or a cyclical trough — price, mix, cost, or a competitor — and whether it is permanent.

And these came back clean

Did the share count rise anyway?
Did debt outgrow the business?
Did receivables and inventory outpace sales?
Are "one-time" charges a yearly habit?

Each test is read from the filings and is noisy alone; a flag can mark a cyclical trough or a year of heavy investment as easily as a problem. The filing says which.

Peers, Health Care Providers & Services

The same industry, side by side on owner economics. Each figure is a through-cycle median, so a peak or trough year can’t distort it; the group median at the foot is the line to read each against.

Company	Revenue	Gross margin	Op. margin	ROIC	Owner earn. margin
SEMSelect Medical Holdings	$5.5B	—	7.6%	7%	5%
AVAHAveanna Healthcare Holdings Inc.	$2.4B	—	1.6%	3%	-2%
AMEDAmedisys	$2.3B	43%	7.0%	4%	6%
CONConcentra Group Holdings Parent Inc.	$2.2B	—	15.5%	17%	10%
PRVAPrivia Health Group	$2.1B	—	1.2%	8%	5%
MDPediatrix Medical Group Inc.	$1.9B	—	10.1%	8%	11%
HCSGHealthcare Services Group	$1.8B	13%	4.4%	15%	2%
ADUSAddus HomeCare	$1.4B	30%	6.6%	8%	8%
Group median	—	—	6.8%	8%	5%

The price

What a price has to assume.

What the price implies

reverse-DCF

Type today's close and see the owner-earnings growth you'd have to believe to justify it, beside what Pediatrix Medical Group Inc. has delivered.

Pediatrix Medical Group Inc.’s latest year runs above its own through-cycle margin — the reported figure may flatter a peak. So the tool opens on the through-cycle base, Graham’s averaging cutting both ways; clear the toggle below to read the latest year exactly as reported.

Today’s price $

Through the cycle, Pediatrix Medical Group Inc. earns about $219M on its 11.4% median owner-earnings margin. This year’s 13.2% margin runs above that; the reported figure may flatter a peak you'd be paying on. Normalize, below, values the price on that through-cycle figure rather than the latest year. It comes pre-checked here for that reason, the same rule that already normalizes a trough; clear it to price the year as filed.

Base Normalize · through-cycle ($219M) Net of stock comp (−$19M) Steady-state · maintenance capex ($240M)

—

The assumptions Required return 9% Years of high growth 10 Terminal growth 2.5%

9.0% = the 4.55% 10-year Treasury (Jul 15, 2026) + 4.45 points of equity premium. The rate you require is yours to set.

Enter a price above to run it.

Implied by the price—

Owner-earnings growth · ’21→’25+25%/yr

Owner-earnings growth · ’16→’25−8%/yr

Owner-earnings yield—

P/E (3-yr earnings ’23–’25)—

P/B—

Graham’s price gate—

Graham capped the multiple at 15×; Buffett and Munger let that rule go: a wonderful business can deserve 50× if the thesis holds. The gate marks the bargain-hunter's floor.

Against a high-grade bond: Graham’s yardstick bond yield%

Prefilled with the 10-year Treasury (4.55%, as of Jul 15, 2026). Edit it for today’s exact figure, or a AAA corporate yield.

Graham measured a stock against the bond you could own instead, the heart of his margin of safety. Enter a price above to weigh the owner-earnings yield against this bond.

Free cash flow $237M on 82M shares outstanding, per the 10-Q cover, as of 2026-05-01; net debt $425M. The base opens on the through-cycle figure (the latest year sits above the record’s own median, and Graham’s averaging cuts both ways); clear Normalize to use the year as filed. Net of stock comp treats option pay as the expense it is. Capex ($21M) runs well above depreciation ($23M), so this is a build-out; Steady-state swaps total capex for maintenance (≈ depreciation), lifting the base to about $240M, the cash it would throw off if it stopped expanding. The dials set the multiple a growth belief justifies; the price, and every dollar on this page, is yours.

Weigh MD against another business →

The owners of MD: the meeting and the votes →

Cite: Owner Scorecard, "Pediatrix Medical Group Inc. (MD), the owner's record," https://ownerscorecard.com/c/MD, data as of 2026-07-09.

Manual order: ← MCY its page in the Manual MDB →

Industry order: ← LFST the Health Care Providers & Services chapter NHC →